Discovery of acetohydroxyacid synthase inhibitors as anti-tuberculosis lead compounds from natural products

Y Niu, Z Wu, Q Hu, Y Wu, Q Jiang, X Yang - Bioorganic & Medicinal …, 2025 - Elsevier
Acetohydroxy acid synthase (AHAS) is a key enzyme that catalyzes the synthesis of
branched-chain amino acids, which is indispensable for the survival and growth of …

The exceptions that prove the rule—a historical view of bedaquiline susceptibility

P Miotto, DM Cirillo, T Schön, CU Köser - Genome Medicine, 2024 - Springer
In the accompanying study, Nimmo and colleagues estimated the dates of emergence of
mutations in mmpR5 (Rv0678), the most important resistance gene to the anti-tuberculosis …

The kinetics of bedaquiline diffusion in tuberculous cavities opens a window for emergence of resistance.

AE Bustion, JP Ernest, F Kaya, C Silva, J Sarathy… - bioRxiv, 2024 - biorxiv.org
Cavitary tuberculosis (TB) is difficult to cure and a site of relapse. Bedaquiline has been a
wonder drug in the treatment of multidrug resistant TB, but emergence of resistance …

Careful classification of potential bedaquiline resistance mutations is critical when analysing their clinical impact

JE Phelan, C Utpatel, N Ismail, T Cortes… - … of Tuberculosis and …, 2024 - ingentaconnect.com
Alliance (New York, NY, USA), and the WHO Regional Office for Europe (Copenhagen,
Denmark). CUK's consulting for Becton Dickinson involves a collaboration with Janssen …